TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Current Assets (2020 - 2025)

Updated

TFA Therapeutics' Current Assets came in at $997,742 for Q4 2025, up 65.8% from $601,602 a year earlier.

Analysis

TFA Therapeutics (RAJAF) Current Assets (2020 - 2025) Analysis & Trends

Going back to Q4 2020, TFA Therapeutics' Current Assets data covers 7 quarters.

  • Current Assets carries a five-year compound annual growth rate of 1.0% (FY2020 to FY2025).
  • Going back by year, Current Assets was $601,602 in FY2024 (+83.9%), $327,175 in FY2023 (-34.8%), $501,552 in FY2022 (-55.6%) and $1.13 million in FY2021 (+19.2%).
  • The Q4 2025 figure represents the highest quarterly Current Assets since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn 26.21 Bn
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn 6.31 Bn
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn 5.90 Bn
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn 7.61 Bn
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn 6.35 Bn
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn 1.52 Bn
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn 1.82 Bn
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn 859.84 Mn
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn 1.19 Bn
10 TFA Therapeutics 1.02 Bn 1.02 Bn - 997,742.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 997,742.00
Dec 31, 2024 601,602.00
Dec 31, 2023 327,175.00
Sep 30, 2023 52,135.00
Dec 31, 2022 501,552.00
Dec 31, 2021 1.13 Mn
Dec 31, 2020 949,007.00
API Access

TFA Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=RAJAF&period=max&api_key=YOUR_API_KEY